Furthermore, the concomitant use of Melan-A with markers such as HMB-45 or S-100 was also recommended in order to avoid the misdiagnosing of “pseudomelanocytic” cells as melanoma cells [38,45]. The gene discussed is PMEL; the disease is melanoma.